- Home
- SLS vs DCGO Comparison
SLS vs DCGO Comparison
Compare SLS & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- DCGO
- Stock Information
- Founded
- SLS 2012
- DCGO 2015
- Country
- SLS United States
- DCGO United States
- Employees
- SLS N/A
- DCGO N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- DCGO Managed Health Care
- Sector
- SLS Health Care
- DCGO Health Care
- Exchange
- SLS Nasdaq
- DCGO Nasdaq
- Market Cap
- SLS 165.6M
- DCGO 144.7M
- IPO Year
- SLS N/A
- DCGO N/A
- Fundamental
- Price
- SLS $1.66
- DCGO $1.33
- Analyst Decision
- SLS Strong Buy
- DCGO Strong Buy
- Analyst Count
- SLS 1
- DCGO 4
- Target Price
- SLS $7.00
- DCGO $3.74
- AVG Volume (30 Days)
- SLS 2.8M
- DCGO 487.7K
- Earning Date
- SLS 08-12-2025
- DCGO 08-07-2025
- Dividend Yield
- SLS N/A
- DCGO N/A
- EPS Growth
- SLS N/A
- DCGO N/A
- EPS
- SLS N/A
- DCGO N/A
- Revenue
- SLS N/A
- DCGO $520,500,658.00
- Revenue This Year
- SLS N/A
- DCGO N/A
- Revenue Next Year
- SLS N/A
- DCGO $4.08
- P/E Ratio
- SLS N/A
- DCGO N/A
- Revenue Growth
- SLS N/A
- DCGO N/A
- 52 Week Low
- SLS $0.77
- DCGO $1.23
- 52 Week High
- SLS $2.27
- DCGO $5.68
- Technical
- Relative Strength Index (RSI)
- SLS 41.18
- DCGO 37.22
- Support Level
- SLS $1.75
- DCGO $1.42
- Resistance Level
- SLS $1.96
- DCGO $1.54
- Average True Range (ATR)
- SLS 0.12
- DCGO 0.09
- MACD
- SLS -0.04
- DCGO -0.01
- Stochastic Oscillator
- SLS 18.56
- DCGO 9.62
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.